These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28361054)

  • 1. Validation and Utilization of a Clinical Next-Generation Sequencing Panel for Selected Cardiovascular Disorders.
    Celestino-Soper PB; Gao H; Lynnes TC; Lin H; Liu Y; Spoonamore KG; Chen PS; Vatta M
    Front Cardiovasc Med; 2017; 4():11. PubMed ID: 28361054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
    Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
    Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanger Validation of High-Throughput Sequencing in Genetic Diagnosis: Still the Best Practice?
    De Cario R; Kura A; Suraci S; Magi A; Volta A; Marcucci R; Gori AM; Pepe G; Giusti B; Sticchi E
    Front Genet; 2020; 11():592588. PubMed ID: 33343633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of Targeted Next-Generation Sequencing Panels for Detection of Germline Variants in Inherited Diseases.
    Santani A; Murrell J; Funke B; Yu Z; Hegde M; Mao R; Ferreira-Gonzalez A; Voelkerding KV; Weck KE
    Arch Pathol Lab Med; 2017 Jun; 141(6):787-797. PubMed ID: 28322587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application.
    Hynst J; Navrkalova V; Pal K; Pospisilova S
    PeerJ; 2021; 9():e10897. PubMed ID: 33850640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
    Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory.
    Simen BB; Yin L; Goswami CP; Davis KO; Bajaj R; Gong JZ; Peiper SC; Johnson ES; Wang ZX
    Arch Pathol Lab Med; 2015 Apr; 139(4):508-17. PubMed ID: 25356985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a next-generation sequencing oncology panel optimized for low input DNA.
    Sussman RT; Shaffer S; Azzato EM; DeSloover D; Farooqi MS; Meyer A; Lieberman DB; Bigdeli A; Paolillo C; Ganapathy K; Sukhadia S; Rosenbaum JN; Daber RD; Morrissette JJD
    Cancer Genet; 2018 Dec; 228-229():55-63. PubMed ID: 30553474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.
    van den Akker J; Mishne G; Zimmer AD; Zhou AY
    BMC Genomics; 2018 Apr; 19(1):263. PubMed ID: 29665779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants.
    Miller EM; Patterson NE; Zechmeister JM; Bejerano-Sagie M; Delio M; Patel K; Ravi N; Quispe-Tintaya W; Maslov A; Simmons N; Castaldi M; Vijg J; Karabakhtsian RG; Greally JM; Kuo DYS; Montagna C
    Oncotarget; 2017 Nov; 8(60):102033-102045. PubMed ID: 29254223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
    de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
    Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
    Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
    J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma.
    Crona J; Ljungström V; Welin S; Walz MK; Hellman P; Björklund P
    PLoS One; 2015; 10(7):e0133210. PubMed ID: 26230854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.